Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

PRAX

Praxis Precision Medicines (PRAX)

Praxis Precision Medicines Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PRAX
DateTimeSourceHeadlineSymbolCompany
01/09/20249:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
01/09/20249:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
12/07/20235:23PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRAXPraxis Precision Medicines Inc
12/07/20235:19PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PRAXPraxis Precision Medicines Inc
12/01/20234:33PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRAXPraxis Precision Medicines Inc
11/28/20237:00AMGlobeNewswire Inc.Praxis Precision Medicines to Showcase Largest Pipeline of Precision Epilepsy Programs and Breadth of Commitment to Epilepsy Treatments at Upcoming MeetingsNASDAQ:PRAXPraxis Precision Medicines Inc
11/21/20234:00PMGlobeNewswire Inc.Praxis Precision Medicines to Present at the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:PRAXPraxis Precision Medicines Inc
11/16/20238:00AMGlobeNewswire Inc.Praxis Precision Medicines Receives PRIME Designation from the EMA for elsunersen (PRAX-222) for Treatment of SCN2A Gain of Function Developmental EpilepsiesNASDAQ:PRAXPraxis Precision Medicines Inc
11/07/20237:37AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRAXPraxis Precision Medicines Inc
11/07/20237:35AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRAXPraxis Precision Medicines Inc
11/07/20237:00AMGlobeNewswire Inc.Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2023 Financial ResultsNASDAQ:PRAXPraxis Precision Medicines Inc
11/06/20234:24PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRAXPraxis Precision Medicines Inc
11/02/20238:00AMGlobeNewswire Inc.Praxis Precision Medicines to Present at Truist Securities BioPharma SymposiumNASDAQ:PRAXPraxis Precision Medicines Inc
10/16/20237:09AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PRAXPraxis Precision Medicines Inc
10/10/20237:41AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
10/04/20237:56AMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:PRAXPraxis Precision Medicines Inc
10/02/20231:27PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRAXPraxis Precision Medicines Inc
10/02/20231:17PMGlobeNewswire Inc.Praxis Precision Medicines Provides Portfolio Update at 2023 R&D DayNASDAQ:PRAXPraxis Precision Medicines Inc
09/27/20234:15PMGlobeNewswire Inc.Praxis Precision Medicines To Host Hybrid R&D Day on Monday, October 2, 2023NASDAQ:PRAXPraxis Precision Medicines Inc
09/19/202310:25AMAllPennyStocks.comBiotech Catches Major Premarket BidNASDAQ:PRAXPraxis Precision Medicines Inc
09/07/20238:00AMGlobeNewswire Inc.Praxis Precision Medicines to Present at H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:PRAXPraxis Precision Medicines Inc
08/31/20238:00AMGlobeNewswire Inc.Praxis Precision Medicines to Present Data from Epilepsy Portfolio at the 35th International Epilepsy CongressNASDAQ:PRAXPraxis Precision Medicines Inc
08/09/20238:31AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRAXPraxis Precision Medicines Inc
08/09/20238:27AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRAXPraxis Precision Medicines Inc
08/09/20237:00AMGlobeNewswire Inc.Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2023 Financial ResultsNASDAQ:PRAXPraxis Precision Medicines Inc
08/08/20237:00AMGlobeNewswire Inc.Praxis Precision Medicines Announces Positive Data from Randomized Withdrawal Sub-Study and Long-Term Extension of Essential1 Study for UlixacaltamideNASDAQ:PRAXPraxis Precision Medicines Inc
08/07/20237:00AMGlobeNewswire Inc.Praxis Precision Medicines Announces Positive Results of EEG Analysis of PRAX-628 Phase 1 StudyNASDAQ:PRAXPraxis Precision Medicines Inc
08/03/20234:12PMGlobeNewswire Inc.Praxis Precision Medicines to Participate at the 2023 Wedbush PacGrow Healthcare ConferenceNASDAQ:PRAXPraxis Precision Medicines Inc
06/30/20234:15PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PRAXPraxis Precision Medicines Inc
06/28/20234:48PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PRAXPraxis Precision Medicines Inc
 Showing the most relevant articles for your search:NASDAQ:PRAX